Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
56°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Renovaro Inc
Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology
March 03, 2025
From
Renovaro Inc
Via
GlobeNewswire
Tickers
POAI
RENB
Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine
February 26, 2025
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Renovaro Announces $15 million in Equity Committed
February 26, 2025
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Renovaro Appoints Nathen Fuentes as Chief Financial Officer
January 07, 2025
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Renovaro Issues Shareholder Letter and Provides Corporate Update
January 07, 2025
From
Renovaro Inc
Via
GlobeNewswire
Tickers
POAI
RENB
Renovaro to Acquire Predictive Oncology in All-Stock Transaction
January 06, 2025
From
Renovaro Inc
Via
GlobeNewswire
Tickers
POAI
RENB
Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV
December 30, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program
December 23, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Renovaro Regains Compliance with NASDAQ Listing Requirement
December 20, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection
December 20, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Renovaro Issues Shareholder Letter and Provides Corporate Update
November 04, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing
October 17, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Renovaro Announces Strategic Restructuring and Leadership Transition
October 16, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics
September 19, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Independent Expert Assessment Validates RenovaroCube’s Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection
September 17, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress
September 13, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
RenovaroCube Announces Strategic Offering of Up to 20% Ownership
September 11, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Renovaro, Inc. Announces $10 million in Equity Committed
June 14, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy
May 24, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics
April 30, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership
April 24, 2024
From
Renovaro Inc
Via
GlobeNewswire
Tickers
RENB
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.